Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	actin binding	MYH7 SPATA31A1 SPATA31A3 MYO1A IQGAP2 MYO6 MYH7B SIPA1L1 SPATA31A7 PPP1R9A DIAPH2 MYO15A SPATA31A5 PDLIM5	1.89e-08	479	87	14	GO:0003779
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH7 SPATA31A1 SPATA31A3 MYO1A IQGAP2 MYO6 MYH7B MYOC SIPA1L1 SPATA31A7 PPP1R9A KIF19 DIAPH2 NAV3 IQCJ-SCHIP1 MYO15A NEDD1 SPATA31A5 PDLIM5 KIF7	3.83e-08	1099	87	20	GO:0008092
GeneOntologyMolecularFunction	ATP-dependent activity	MYH7 MYO1A CCT3 MYO6 MYH7B DDX60 DHX38 KIF19 ERCC6L2 NAV3 NAV2 ABCC2 MYO15A HSPA9 KIF7	5.96e-08	614	87	15	GO:0140657
GeneOntologyMolecularFunction	microfilament motor activity	MYH7 MYO1A MYO6 MYH7B MYO15A	6.26e-07	38	87	5	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH7 MYO1A MYO6 MYH7B KIF19 MYO15A KIF7	8.32e-07	118	87	7	GO:0003774
GeneOntologyMolecularFunction	actin filament binding	MYH7 MYO1A IQGAP2 MYO6 MYH7B SIPA1L1 PPP1R9A MYO15A	6.66e-06	227	87	8	GO:0051015
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH7 CCT3 DDX60 DHX38 KIF19 NAV3 NAV2 ABCC2 HSPA9 KIF7	2.19e-05	441	87	10	GO:0016887
GeneOntologyMolecularFunction	calmodulin binding	MYH7 MYO1A IQGAP2 MYO6 ASPM IQCJ-SCHIP1 MYO15A	6.56e-05	230	87	7	GO:0005516
GeneOntologyMolecularFunction	cell-cell adhesion mediator activity	CNTN5 PKP2 PDLIM5 CNTN1	1.45e-04	61	87	4	GO:0098632
GeneOntologyMolecularFunction	cell adhesion mediator activity	CNTN5 PKP2 PDLIM5 CNTN1	3.40e-04	76	87	4	GO:0098631
GeneOntologyMolecularFunction	pyrophosphatase activity	MYH7 CCT3 DCP1B DDX60 DHX38 KIF19 NAV3 NAV2 ABCC2 HSPA9 KIF7	1.03e-03	839	87	11	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	MYH7 CCT3 DCP1B DDX60 DHX38 KIF19 NAV3 NAV2 ABCC2 HSPA9 KIF7	1.04e-03	840	87	11	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	MYH7 CCT3 DCP1B DDX60 DHX38 KIF19 NAV3 NAV2 ABCC2 HSPA9 KIF7	1.04e-03	840	87	11	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	MYH7 CCT3 DDX60 DHX38 KIF19 NAV3 NAV2 ABCC2 HSPA9 KIF7	1.97e-03	775	87	10	GO:0017111
GeneOntologyMolecularFunction	protein phosphatase activator activity	PPP2R5A PPP2R5E	2.45e-03	17	87	2	GO:0072542
GeneOntologyBiologicalProcess	supramolecular fiber organization	SLAIN2 FAM171A1 MYH7 MYO1A IQGAP2 ADAMTS3 MYO6 MYOC PPP1R9A KIF19 DIAPH2 MKX NAV3 PKP2 CGNL1 MYO15A NEDD1 PCM1	7.88e-08	957	87	18	GO:0097435
GeneOntologyBiologicalProcess	actin filament-based process	FAM171A1 MYH7 MYO1A IQGAP2 MYO6 MYH7B MYOC SIPA1L1 PPP1R9A DIAPH2 PKP2 CGNL1 MYO15A PDLIM5	2.64e-05	912	87	14	GO:0030029
GeneOntologyCellularComponent	myosin complex	MYH7 MYO1A MYO6 MYH7B CGNL1 MYO15A	1.76e-07	59	88	6	GO:0016459
GeneOntologyCellularComponent	actin cytoskeleton	MYH7 MYO1A IQGAP2 MYO6 MYH7B SIPA1L1 PPP1R9A DIAPH2 CGNL1 MYO15A PDLIM5	2.97e-05	576	88	11	GO:0015629
GeneOntologyCellularComponent	supramolecular fiber	SLAIN2 MYH7 PPP2R5A MYO1A CCT3 IQGAP2 MYO6 MYH7B KIF19 ASPM DIAPH2 NAV3 PKP2 PDLIM5 KIF7	1.11e-04	1179	88	15	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	SLAIN2 MYH7 PPP2R5A MYO1A CCT3 IQGAP2 MYO6 MYH7B KIF19 ASPM DIAPH2 NAV3 PKP2 PDLIM5 KIF7	1.20e-04	1187	88	15	GO:0099081
GeneOntologyCellularComponent	pericentriolar material	DYNC2I1 NEDD1 PCM1	2.19e-04	28	88	3	GO:0000242
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	SLAIN2 MYO1A CCT3 IQGAP2 MYO6 KIF19 ASPM DIAPH2 NAV3 PKP2 PDLIM5 KIF7	3.77e-04	899	88	12	GO:0099513
GeneOntologyCellularComponent	filamentous actin	MYO1A MYO6 PDLIM5	5.47e-04	38	88	3	GO:0031941
GeneOntologyCellularComponent	microtubule end	SLAIN2 ASPM NAV3	5.47e-04	38	88	3	GO:1990752
GeneOntologyCellularComponent	actin-based cell projection	MYO1A PTPRH IQGAP2 MYO6 PPP1R9A MYO15A	1.14e-03	278	88	6	GO:0098858
Domain	IQ	MYH7 MYO1A IQGAP2 MYO6 MYH7B ASPM MYO15A	7.67e-08	81	84	7	SM00015
Domain	IQ_motif_EF-hand-BS	MYH7 MYO1A IQGAP2 MYO6 MYH7B ASPM MYO15A	1.60e-07	90	84	7	IPR000048
Domain	IQ	MYH7 MYO1A IQGAP2 MYO6 MYH7B ASPM MYO15A	2.00e-07	93	84	7	PS50096
Domain	Myosin_head_motor_dom	MYH7 MYO1A MYO6 MYH7B MYO15A	7.29e-07	38	84	5	IPR001609
Domain	MYOSIN_MOTOR	MYH7 MYO1A MYO6 MYH7B MYO15A	7.29e-07	38	84	5	PS51456
Domain	Myosin_head	MYH7 MYO1A MYO6 MYH7B MYO15A	7.29e-07	38	84	5	PF00063
Domain	MYSc	MYH7 MYO1A MYO6 MYH7B MYO15A	7.29e-07	38	84	5	SM00242
Domain	P-loop_NTPase	CACNB1 MYH7 MYO1A MYO6 MYH7B DDX60 DHX38 KIF19 ASPM ERCC6L2 NAV3 NAV2 NLRC5 ABCC2 MYO15A KIF7	9.97e-07	848	84	16	IPR027417
Domain	IQ	MYO1A IQGAP2 MYO6 ASPM MYO15A	1.68e-05	71	84	5	PF00612
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	1.88e-05	12	84	3	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	1.88e-05	12	84	3	IPR027970
Domain	Myosin_tail_1	MYH7 MYH7B CGNL1	6.82e-05	18	84	3	PF01576
Domain	Myosin_tail	MYH7 MYH7B CGNL1	6.82e-05	18	84	3	IPR002928
Domain	Myosin-like_IQ_dom	MYH7 MYH7B ASPM	8.07e-05	19	84	3	IPR027401
Domain	-	MYH7 MYH7B ASPM	8.07e-05	19	84	3	4.10.270.10
Domain	PP2A_B56	PPP2R5A PPP2R5E	1.98e-04	5	84	2	IPR002554
Domain	B56	PPP2R5A PPP2R5E	1.98e-04	5	84	2	PF01603
Domain	CH	IQGAP2 ASPM NAV3 NAV2	2.09e-04	65	84	4	SM00033
Domain	CH	IQGAP2 ASPM NAV3 NAV2	2.78e-04	70	84	4	PF00307
Domain	-	IQGAP2 ASPM NAV3 NAV2	2.94e-04	71	84	4	1.10.418.10
Domain	CH	IQGAP2 ASPM NAV3 NAV2	3.27e-04	73	84	4	PS50021
Domain	CH-domain	IQGAP2 ASPM NAV3 NAV2	3.63e-04	75	84	4	IPR001715
Domain	Myosin_N	MYH7 MYH7B	2.02e-03	15	84	2	PF02736
Domain	Myosin_N	MYH7 MYH7B	2.02e-03	15	84	2	IPR004009
Domain	TSP_1	ADAMTS3 ADGRB2 RSPO1	2.87e-03	63	84	3	PF00090
Domain	Furin_repeat	IGF1R RSPO1	2.92e-03	18	84	2	IPR006212
Domain	FU	IGF1R RSPO1	2.92e-03	18	84	2	SM00261
Domain	TSP1	ADAMTS3 ADGRB2 RSPO1	3.14e-03	65	84	3	SM00209
Domain	TSP1_rpt	ADAMTS3 ADGRB2 RSPO1	3.14e-03	65	84	3	IPR000884
Domain	TSP1	ADAMTS3 ADGRB2 RSPO1	3.14e-03	65	84	3	PS50092
Domain	ARM-type_fold	PPP2R5A PPP2R5E ASPM DIAPH2 PKP2 LRBA	4.24e-03	339	84	6	IPR016024
Domain	Kazal_1	SPARCL1 SPINK5	4.36e-03	22	84	2	PF00050
Domain	fn3	IGF1R PTPRH CNTN5 CNTN1	6.15e-03	162	84	4	PF00041
Domain	WD40	TULP4 DYNC2I1 LRBA NEDD1 WIPI2	6.26e-03	259	84	5	PF00400
Domain	-	CACNB1 DDX60 DHX38 ERCC6L2 NAV3 NAV2 NLRC5 ABCC2 MYO15A	6.27e-03	746	84	9	3.40.50.300
Domain	S100_CABP	RPTN FLG2	6.52e-03	27	84	2	PS00303
Domain	S_100	RPTN FLG2	6.52e-03	27	84	2	PF01023
Domain	S100_Ca-bd_sub	RPTN FLG2	7.00e-03	28	84	2	IPR013787
Domain	S100/CaBP-9k_CS	RPTN FLG2	7.00e-03	28	84	2	IPR001751
Domain	S_100	RPTN FLG2	7.00e-03	28	84	2	SM01394
Domain	WD40	TULP4 DYNC2I1 LRBA NEDD1 WIPI2	7.20e-03	268	84	5	SM00320
Domain	ARM-like	PPP2R5A PPP2R5E ASPM PKP2 LRBA	7.43e-03	270	84	5	IPR011989
Domain	WD40_repeat	TULP4 DYNC2I1 LRBA NEDD1 WIPI2	7.66e-03	272	84	5	IPR001680
Domain	WD_REPEATS_1	TULP4 DYNC2I1 LRBA NEDD1 WIPI2	8.37e-03	278	84	5	PS00678
Domain	WD_REPEATS_2	TULP4 DYNC2I1 LRBA NEDD1 WIPI2	8.49e-03	279	84	5	PS50082
Domain	WD_REPEATS_REGION	TULP4 DYNC2I1 LRBA NEDD1 WIPI2	8.49e-03	279	84	5	PS50294
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SFXN1 SLAIN2 CCT3 IQGAP2 UBR5 MYO6 LEMD3 SURF6 KDM3B PKP2 CGNL1 LRBA FLG2 MGA TASOR HSPA9 PCM1	1.22e-11	777	89	17	35844135
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A1 SPATA31A3 SPATA31A7 SPATA31A5	5.99e-10	6	89	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A1 SPATA31A3 SPATA31A7 SPATA31A5	5.99e-10	6	89	4	25930072
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	FAM171A1 CACNB1 RANBP2 CCT3 IQGAP2 UBR5 FAM120C SIPA1L1 PPP1R9A ADGRB2 DIAPH2 MGA HSPA9 PCM1 CNTN1 KIF7	2.81e-09	963	89	16	28671696
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A1 SPATA31A3 ADAMTS3 SPATA31A7 SPATA31A5	4.01e-09	24	89	5	32212159
Pubmed	Novel myosin mutations for hereditary hearing loss revealed by targeted genomic capture and massively parallel sequencing.	MYH7 MYO6 MYO15A	1.62e-08	3	89	3	24105371
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SLAIN2 ZNF609 PPP2R5A TUT4 PPP2R5E UBR5 FAM120C TNFSF13B SIPA1L1 SURF6 ASPM PKP2 MGA PSMG3-AS1 PCM1 KIF7	2.23e-08	1116	89	16	31753913
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	FAM171A1 MYO6 FAM120C SIPA1L1 SURF6 PKP2 PCM1	3.53e-08	125	89	7	29467281
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	IRF2BP2 RANBP2 CCT3 MYO6 SURF6 DHX38 KDM3B CGNL1 LRBA NEDD1 TASOR HSPA9 PDLIM5 PCM1	1.09e-07	934	89	14	33916271
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SLAIN2 IRF2BP2 RANBP2 ZNF609 MYO6 DHX38 KDM3B ZMYM1 NEDD1 MGA	2.15e-07	444	89	10	34795231
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF609 TUT4 DCP1B LEMD3 KDM3B DYNC2I1 ZMYM1 NEDD1 MGA TASOR PDLIM5 PCM1	3.79e-07	733	89	12	34672954
Pubmed	Myosins: a diverse superfamily.	MYO1A MYO6 MYO15A	5.63e-07	7	89	3	10722873
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	SFXN1 A2M RANBP2 MYH7 MYO1A UBR5 MYO6 MYH7B LRBA FLG2 HSPA9	8.34e-07	647	89	11	26618866
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	SLAIN2 RANBP2 ZNF609 PPP2R5A PPP2R5E CCT3 UBR5 LEMD3 DHX38 ASPM DYNC2I1 ZMYM1 NEDD1 PCM1	1.38e-06	1155	89	14	20360068
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SLAIN2 RANBP2 UBR5 SIPA1L1 DYNC2I1 CGNL1 NEDD1 MGA HSPA9 PDLIM5 PCM1 KIF7	1.85e-06	853	89	12	28718761
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FAM120C DDX60 ASPM CGNL1 LRBA FLG2 HSPA9	2.46e-06	234	89	7	36243803
Pubmed	Functional proteomics mapping of a human signaling pathway.	A2M PPP2R5E DCP1B UBR5 MYO6 LEMD3 KDM3B PKP2 SPARCL1 MGA	2.84e-06	591	89	10	15231748
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	A2M IRF2BP2 RANBP2 CCT3 MYO6 PKP2 FLG2 HSPA9 PCM1	3.84e-06	477	89	9	31300519
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	RANBP2 ERCC4 CCT3 UBR5 DHX38 KDM3B MGA HSPA9	3.91e-06	357	89	8	37059091
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	RANBP2 MYH7 CCT3 IQGAP2 MYO6 SIPA1L1 PKP2 FLG2 HSPA9 PCM1	4.72e-06	626	89	10	33644029
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	IRF2BP2 IGF1R MYO6 SURF6 KIF19 ERCC6L2 DIAPH2 NAV2 LRBA	5.34e-06	497	89	9	36774506
Pubmed	Interaction of myocilin with the C-terminal region of hevin.	MYOC SPARCL1	6.48e-06	2	89	2	16316624
Pubmed	Inhibition of IGF-IR increases chemosensitivity in human colorectal cancer cells through MRP-2 promoter suppression.	IGF1R ABCC2	6.48e-06	2	89	2	22275271
Pubmed	The effect of novel mutations on the structure and enzymatic activity of unconventional myosins associated with autosomal dominant non-syndromic hearing loss.	MYO1A MYO6	6.48e-06	2	89	2	25080041
Pubmed	Restoration of cytoskeletal and membrane tethering defects but not defects in membrane trafficking in the intestinal brush border of mice lacking both myosin Ia and myosin VI.	MYO1A MYO6	6.48e-06	2	89	2	26286357
Pubmed	Multiple mutations of MYO1A, a cochlear-expressed gene, in sensorineural hearing loss.	MYO1A MYO6	6.48e-06	2	89	2	12736868
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SLAIN2 IRF2BP2 UBR5 SIPA1L1 MGA PCM1	8.16e-06	184	89	6	32908313
Pubmed	JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase.	RANBP2 NEDD1 HSPA9	8.86e-06	16	89	3	26291670
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	SFXN1 IRF2BP2 PPP2R5A PPP2R5E IQGAP2 MYO6 GOLIM4 PKP2 HSPA9	1.38e-05	560	89	9	35241646
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	FAM171A1 RANBP2 ZNF609 PPP2R5A PPP2R5E PTPRH CCT3 LEMD3 PPP1R9A DHX38 GOLIM4 KIF7	1.49e-05	1049	89	12	27880917
Pubmed	Human transcription factor protein interaction networks.	SFXN1 IRF2BP2 ZNF609 ERCC4 CCT3 DCP1B MYO6 SURF6 RLIM ZMYM1 FLG2 MGA PCM1 KIF7	1.57e-05	1429	89	14	35140242
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	CCT3 MYH7B DDX60 SIPA1L1 HSPA9 PHTF1	1.64e-05	208	89	6	33230847
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SFXN1 RANBP2 ZNF609 TUT4 MYO6 FAM120C DDX60 ZMYM1 MGA PDLIM5	1.66e-05	724	89	10	36232890
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	CCT3 MYO6 LEMD3 SIPA1L1 PKP2 HSPA9 PDLIM5	1.71e-05	315	89	7	26777405
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RANBP2 MYH7 MYO1A CCT3 IQGAP2 TTC16 MYH7B PPP1R9A ASPM NAV2 ABCC2 TASOR HSPA9 PHTF1	1.73e-05	1442	89	14	35575683
Pubmed	Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.	PPP2R5A PPP2R5E	1.94e-05	3	89	2	32847850
Pubmed	Nuclear translocation of IGF-1R via p150(Glued) and an importin-β/RanBP2-dependent pathway in cancer cells.	RANBP2 IGF1R	1.94e-05	3	89	2	24909165
Pubmed	Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans.	NAV3 NAV2	1.94e-05	3	89	2	12079279
Pubmed	Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.	NAV3 NAV2	1.94e-05	3	89	2	15158073
Pubmed	Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications.	MYOC SPARCL1	1.94e-05	3	89	2	20926826
Pubmed	Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms.	NAV3 NAV2	1.94e-05	3	89	2	12062803
Pubmed	The antagonistic action of B56-containing protein phosphatase 2As and casein kinase 2 controls the phosphorylation and Gli turnover function of Daz interacting protein 1.	PPP2R5A PPP2R5E	1.94e-05	3	89	2	21878643
Pubmed	IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers.	IGF1R CD34	1.94e-05	3	89	2	29951828
Pubmed	COBL, MKX and MYOC Are Potential Regulators of Brown Adipose Tissue Development Associated with Obesity-Related Metabolic Dysfunction in Children.	MYOC MKX	1.94e-05	3	89	2	36834493
Pubmed	FAM188B enhances cell survival via interaction with USP7.	UBR5 HSPA9 PCM1 KIF7	2.41e-05	65	89	4	29795372
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SFXN1 ZNF609 TUT4 IGF1R TULP4 MYO6 FAM120C PPP1R9A AFF3 NLRC5 DYNC2I1 LRBA NEDD1 PCM1	2.47e-05	1489	89	14	28611215
Pubmed	Genetic Hearing Loss Overview	MYO1A MYO6 DSPP MYO15A	3.23e-05	70	89	4	20301607
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	TUT4 CCT3 UBR5 SIPA1L1 DIAPH2 PCM1	3.25e-05	235	89	6	30258100
Pubmed	SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.	RANBP2 CCT3 MYO6 PKP2 MGA HSPA9 PCM1	3.53e-05	353	89	7	27545878
Pubmed	A human MAP kinase interactome.	RANBP2 CCT3 MYO6 DIAPH2 NAV3 NAV2 CGNL1 MGA	3.60e-05	486	89	8	20936779
Pubmed	Glycosylphosphatidylinositol anchored recognition molecules that function in axonal fasciculation, growth and guidance in the nervous system.	CNTN5 CNTN1	3.87e-05	4	89	2	1838307
Pubmed	Mechanotransduction in mouse inner ear hair cells requires transmembrane channel-like genes.	MYO6 MYO15A	3.87e-05	4	89	2	22105175
Pubmed	Myo15 function is distinct from Myo6, Myo7a and pirouette genes in development of cochlear stereocilia.	MYO6 MYO15A	3.87e-05	4	89	2	12966030
Pubmed	Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles.	MYH7 MYH7B	3.87e-05	4	89	2	19948655
Pubmed	In-depth genetic and molecular characterization of diaphanous related formin 2 (DIAPH2) and its role in the inner ear.	MYO6 DIAPH2	3.87e-05	4	89	2	36689403
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MYO1A DCP1B UBR5 MYO6 RPTN SIPA1L1 PPP1R9A DHX38 KDM3B FEM1A KIF7	5.19e-05	1005	89	11	19615732
Pubmed	The variable subunit associated with protein phosphatase 2A0 defines a novel multimember family of regulatory subunits.	PPP2R5A PPP2R5E	6.44e-05	5	89	2	8694763
Pubmed	Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12.	PPP2R5A PPP2R5E	6.44e-05	5	89	2	8812429
Pubmed	Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice.	PPP2R5A PPP2R5E	6.44e-05	5	89	2	15095873
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLAIN2 FAM171A1 IGF1R DCP1B SIPA1L1 KDM3B NAV2 PKP2 CGNL1 PCM1	7.15e-05	861	89	10	36931259
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SLAIN2 RANBP2 DDX60 KDM3B FLG2 MGA	7.31e-05	272	89	6	31010829
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	SFXN1 RANBP2 ZNF609 IGF1R CCT3 TULP4 MYO6 SIPA1L1 PKP2 MGA HSPA9 PDLIM5	7.97e-05	1247	89	12	27684187
Pubmed	Genomics and hearing impairment.	MYO6 MYO15A	9.65e-05	6	89	2	9927480
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RANBP2 ZNF609 UBR5 LRBA MGA TASOR PCM1	1.02e-04	418	89	7	34709266
Pubmed	Stabilization of the methyl-CpG binding protein ZBTB38 by the deubiquitinase USP9X limits the occurrence and toxicity of oxidative stress in human cells.	CCT3 UBR5 MGA PDLIM5	1.07e-04	95	89	4	29490077
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	PPP2R5A PPP2R5E PTPRH CCT3 UBR5 MYO6 PPP1R9A DHX38	1.13e-04	573	89	8	28330616
Pubmed	Control of APC/C-dependent ubiquitin chain elongation by reversible phosphorylation.	PPP2R5A PPP2R5E CCT3	1.18e-04	37	89	3	26811472
Pubmed	Cochlear developmental defect and background-dependent hearing thresholds in the Jackson circler (jc) mutant mouse.	MYO6 MYO15A	1.35e-04	7	89	2	16962269
Pubmed	Tails of unconventional myosins.	MYO6 MYO15A	1.35e-04	7	89	2	11212352
Pubmed	The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm.	PPP2R5A PPP2R5E	1.35e-04	7	89	2	8703017
Pubmed	Identification of a new family of protein phosphatase 2A regulatory subunits.	PPP2R5A PPP2R5E	1.35e-04	7	89	2	7592815
Pubmed	Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension.	NAV3 NAV2	1.35e-04	7	89	2	25065758
Pubmed	Helios is a key transcriptional regulator of outer hair cell maturation.	MYO6 MYO15A	1.35e-04	7	89	2	30464345
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	SFXN1 RANBP2 UBR5 LRBA HSPA9	1.56e-04	197	89	5	31620119
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SFXN1 CACNB1 RANBP2 TUT4 FAM120C SIPA1L1 ADGRB2 NAV3 SPARCL1 HSPA9 PCM1	1.57e-04	1139	89	11	36417873
Pubmed	Expression, functional, and structural analysis of proteins critical for otoconia development.	DSPP SPARCL1	1.79e-04	8	89	2	20803598
Pubmed	TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.	A2M MYH7 HSPA9	1.86e-04	43	89	3	31992359
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DCP1B UBR5 SIPA1L1 PCM1 WIPI2	2.06e-04	209	89	5	36779422
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	MYO6 SIPA1L1 RLIM TASOR KIF7	2.20e-04	212	89	5	33853758
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	A2M RANBP2 FAM120C SIPA1L1 NAV3 NEDD1 PCM1	2.23e-04	475	89	7	31040226
Pubmed	A protein interaction landscape of breast cancer.	UBR5 MYO6 DDX60 NAV2 GOLIM4 ZMYM1 PDLIM5 PCM1	2.25e-04	634	89	8	34591612
Pubmed	A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.	PPP2R5A PPP2R5E CCT3	2.27e-04	46	89	3	18782753
Pubmed	Apoptosis Inducing Factor Binding Protein PGAM5 Triggers Mitophagic Cell Death That Is Inhibited by the Ubiquitin Ligase Activity of X-Linked Inhibitor of Apoptosis.	SFXN1 HSPA9	2.30e-04	9	89	2	27218139
Pubmed	The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling.	IGF1R UBR5	2.30e-04	9	89	2	22033112
Pubmed	Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression.	PPP2R5A PPP2R5E	2.30e-04	9	89	2	23345399
Pubmed	De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.	PPP2R5A PPP2R5E	2.30e-04	9	89	2	30595372
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	DCP1B TSBP1 SIPA1L1 CNTN5 NAV2 PKP2 MYO15A PHTF1 KIF7	2.41e-04	814	89	9	23251661
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	SFXN1 CCT3 IQGAP2 UBR5 MGA	2.66e-04	221	89	5	29991511
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L A2M ZNF609 ERCC4 DHX38 DIAPH2 KDM3B TASOR	2.67e-04	650	89	8	38777146
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	IRF2BP2 RANBP2 ERCC4 AFF3 MGA	2.72e-04	222	89	5	37071664
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L TULP4 MYO6 DHX38 CGNL1 MGA TASOR	2.79e-04	493	89	7	15368895
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PPP2R5E CCT3 IQGAP2 MYO6 FAM120C SIPA1L1 PPP1R9A CGNL1 HSPA9 PDLIM5 PCM1 CNTN1	2.86e-04	1431	89	12	37142655
Pubmed	Secreted factor R-Spondin 2 is involved in refinement of patterning of the mammalian cochlea.	MYO6 RSPO1	2.88e-04	10	89	2	23192966
Pubmed	Rho-family GTPase 1 (Rnd1) is a biomechanical stress-sensitive activator of cardiomyocyte hypertrophy.	MYH7 NEDD1	2.88e-04	10	89	2	30797814
Pubmed	The transcription factor GATA-6 regulates pathological cardiac hypertrophy.	MYH7 ADAMTS3	2.88e-04	10	89	2	20705924
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	CCT3 DCP1B NEDD1 PDLIM5 PCM1	2.95e-04	226	89	5	25900982
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	SFXN1 IRF2BP2 RANBP2 ZNF609 CCT3 IQGAP2 HSPA9 PCM1	3.10e-04	665	89	8	30457570
Pubmed	Control of p21Cip by BRCA1-associated protein is critical for cardiomyocyte cell cycle progression and survival.	MYH7 PCM1	3.51e-04	11	89	2	31286143
Pubmed	Restoring physiological cell heterogeneity in the mesenchyme during tooth engineering.	DSPP CD34	3.51e-04	11	89	2	23319349
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	SFXN1 A2M CCT3 MYO6 DDX60 SIPA1L1 SURF6 DHX38 PKP2 FLG2 HSPA9	3.64e-04	1257	89	11	36526897
Interaction	APC interactions	RANBP2 PPP2R5A UBR5 MYO6 FAM120C NAV3 NAV2 PKP2 CGNL1 KIF7	6.82e-06	389	87	10	int:APC
Interaction	BICD1 interactions	RANBP2 UBR5 CGNL1 NEDD1 HSPA9 PDLIM5 PCM1 KIF7	1.26e-05	250	87	8	int:BICD1
Interaction	MAD2L1 interactions	IGF1R ERCC4 UBR5 PPP1R9A KDM3B FLG2 MGA KIF7	1.33e-05	252	87	8	int:MAD2L1
Interaction	ARL16 interactions	SFXN1 MYO6 MGA TASOR PCM1	2.97e-05	83	87	5	int:ARL16
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	1.03e-04	8	89	2	chr9q12
Cytoband	Ensembl 112 genes in cytogenetic band chr4q22	DSPP SPARCL1 PDLIM5	4.13e-04	74	89	3	chr4q22
GeneFamily	EF-hand domain containing\|S100 fused type protein family	RPTN FLG2	2.18e-04	7	59	2	1350
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R5A PPP2R5E	1.07e-03	15	59	2	696
GeneFamily	Myosin heavy chains	MYH7 MYH7B	1.07e-03	15	59	2	1098
GeneFamily	WD repeat domain containing	TULP4 DYNC2I1 LRBA NEDD1 WIPI2	1.63e-03	262	59	5	362
GeneFamily	Fibronectin type III domain containing	IGF1R PTPRH CNTN5 CNTN1	1.84e-03	160	59	4	555
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SECISBP2L FAM171A1 RANBP2 PPP2R5A TUT4 IGF1R PPP2R5E UBR5 SIPA1L1 NAV3 KDM3B TASOR PDLIM5	5.49e-06	856	88	13	M4500
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF609 IGF1R SIPA1L1 PPP1R9A AFF3 DIAPH2 NAV2 LRBA	5.87e-09	196	89	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF609 IGF1R SIPA1L1 PPP1R9A AFF3 DIAPH2 NAV2 LRBA	6.36e-09	198	89	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	A2M ADAMTS3 DIAPH2 NAV3 NAV2 SPARCL1 IQCJ-SCHIP1	1.46e-07	198	89	7	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAM171A1 TUT4 UBR5 PPP1R9A DIAPH2 SPARCL1 FAM124B	1.56e-07	200	89	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A TUT4 PPP1R9A DIAPH2 SPARCL1 FAM124B	1.56e-07	200	89	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 DDX60 CD34 AFF3 NLRC5	2.08e-06	187	89	6	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 DDX60 CD34 AFF3 NLRC5	2.42e-06	192	89	6	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MYH7 DCP1B PPP1R9A PKP2 IQCJ-SCHIP1 PDLIM5	2.49e-06	193	89	6	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A CD34 PPP1R9A SPARCL1 FAM124B	2.49e-06	193	89	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A CD34 PPP1R9A NAV3 FAM124B	2.49e-06	193	89	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 TULP4 MYO6 NAV2 MGA PCM1	2.64e-06	195	89	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M FAM171A1 TNFSF13B CD34 SPARCL1 SPINK5	2.89e-06	198	89	6	f8a6a75c9f2fbe32a22b14b6a029411c73c09f68
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	SLAIN2 PPP2R5E IQGAP2 MYO6 RLIM CNTN1	2.97e-06	199	89	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	SLAIN2 PPP2R5E IQGAP2 MYO6 RLIM DYNC2I1	2.97e-06	199	89	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF609 IGF1R UBR5 PPP1R9A AFF3 LRBA	2.97e-06	199	89	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A PPP1R9A SPARCL1 IQCJ-SCHIP1 FAM124B	3.06e-06	200	89	6	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A MYO6 CD34 SPARCL1 FAM124B	3.06e-06	200	89	6	b1fadb2b5e37e0f51e079d8409c2647eef68dc3b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A TUT4 PPP1R9A SPARCL1 FAM124B	3.06e-06	200	89	6	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A MYO6 CD34 AFF3 SPARCL1	3.06e-06	200	89	6	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	A2M TNFSF13B RNF25 FLG2 SPINK5	8.22e-06	137	89	5	dd5364a1002650d21e0c83d8c701b5f7b09d1c19
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SECISBP2L SLAIN2 ZNF609 ADAMTS3 SPINK5	1.91e-05	163	89	5	d2fcd6f561748f7d29a051c504f016952ba32d0f
ToppCell	Control-Endothelial_cells-Systemic_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	FAM171A1 ADAMTS3 CD34 NAV3 SPARCL1	2.47e-05	172	89	5	c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M IGF1R DDX60 TNFSF13B GOLIM4	2.47e-05	172	89	5	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	Ionocyte-iono-2\|World / Class top	PPP2R5A NAPEPLD SURF6 AFF3 CGNL1	2.54e-05	173	89	5	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	MYO6 PPP1R9A NAV2 IQCJ-SCHIP1 CGNL1	2.99e-05	179	89	5	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A MYO6 CD34 AFF3	3.07e-05	180	89	5	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO6 PPP1R9A SPARCL1 MYO15A CNTN1	3.32e-05	183	89	5	262387ee8d43b96e5f1a77c75124459a506a6172
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO6 PPP1R9A SPARCL1 MYO15A CNTN1	3.32e-05	183	89	5	c85a707acbcb582912e8ac080a36d05f91cfd7a2
ToppCell	IPF-Lymphoid-ILC_B\|Lymphoid / Disease state, Lineage and Cell class	TNFSF13B PPP1R9A AFF3 GOLIM4 FAM124B	3.32e-05	183	89	5	9b507547e6adf78e46e7f542cd9958224ec5826a
ToppCell	Endothelial-A-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	A2M FAM171A1 CD34 SPARCL1 FAM124B	3.68e-05	187	89	5	fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A MYO6 CD34 AFF3	3.77e-05	188	89	5	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M CD34 AFF3 NAV3 SPARCL1	3.77e-05	188	89	5	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	Endothelial-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	A2M FAM171A1 CD34 SPARCL1 FAM124B	3.77e-05	188	89	5	0824d567356d360fd8e78e840c30529c139f98a1
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	IGF1R UBR5 MYO6 NAV2 CGNL1	3.77e-05	188	89	5	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Control-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	FAM171A1 CD34 NAV3 SPARCL1 IQCJ-SCHIP1	3.87e-05	189	89	5	c76d8af2e0aa4a83ee0c3439c894566fbf117dd3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	3.87e-05	189	89	5	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCT3 IQGAP2 CD34 PPP1R9A HSPA9	3.87e-05	189	89	5	533685a921a65d84107d8d33c43b4fffde019143
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	3.87e-05	189	89	5	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	Endothelial-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	A2M FAM171A1 CD34 SPARCL1 FAM124B	3.87e-05	189	89	5	04b565855f58ca0f343904d04be657b66e109076
ToppCell	facs-Marrow-KLS-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCT3 IQGAP2 CD34 PPP1R9A HSPA9	3.87e-05	189	89	5	dca56ab02bf0505f9a352ff907edaef30906d854
ToppCell	facs-Marrow-KLS-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCT3 IQGAP2 CD34 PPP1R9A HSPA9	3.97e-05	190	89	5	a513c1e7df62c28128c932a68b252ee8f0255172
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A MYO6 CD34 AFF3	3.97e-05	190	89	5	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	A2M FAM171A1 CD34 SPARCL1 FAM124B	4.07e-05	191	89	5	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	4.07e-05	191	89	5	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	SECISBP2L MYO6 PPP1R9A NAV2 CGNL1	4.07e-05	191	89	5	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	4.07e-05	191	89	5	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	4.17e-05	192	89	5	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV3 NAV2 CNTN1	4.17e-05	192	89	5	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A MYO6 CD34 AFF3	4.17e-05	192	89	5	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MYH7 MYH7B PPP1R9A PKP2 PDLIM5	4.17e-05	192	89	5	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A MYO6 CD34 AFF3	4.17e-05	192	89	5	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MYO6 PPP1R9A AFF3 NAV2 CGNL1	4.17e-05	192	89	5	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	4.17e-05	192	89	5	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A CD34 PPP1R9A FAM124B	4.27e-05	193	89	5	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	PND03-Epithelial-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH7 PPP1R9A NAV2 PKP2 SPINK5	4.27e-05	193	89	5	5dfa69a680a0859900141c40a446d217aaa747d3
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH7 PPP1R9A NAV2 PKP2 SPINK5	4.27e-05	193	89	5	ebea35704ac5d21e947ae094313cf2a5205e7014
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A MYO6 CD34 AFF3	4.27e-05	193	89	5	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A CD34 PPP1R9A FAM124B	4.27e-05	193	89	5	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A CD34 PPP1R9A AFF3	4.27e-05	193	89	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO6 SPARCL1 CGNL1 MYO15A CNTN1	4.27e-05	193	89	5	f27e2be497745098b5269aa799dd3d5f62d78ba7
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A CD34 PPP1R9A AFF3	4.27e-05	193	89	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PPP2R5A MYO6 CD34 AFF3	4.27e-05	193	89	5	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IGF1R MYO6 PPP1R9A CGNL1 LRBA	4.27e-05	193	89	5	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 CD34 AFF3 NLRC5	4.27e-05	193	89	5	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 UBR5 PPP1R9A LRBA PCM1	4.27e-05	193	89	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO6 SPARCL1 CGNL1 MYO15A CNTN1	4.27e-05	193	89	5	4ccf984baebbb13ae916727137ce593fda7514a2
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	4.38e-05	194	89	5	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS3 MKX NAV3 NAV2 CNTN1	4.38e-05	194	89	5	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M FAM171A1 AFF3 NAV3 SPARCL1	4.38e-05	194	89	5	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO6 PPP1R9A AFF3 NAV2 CGNL1	4.38e-05	194	89	5	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 IGF1R CD34 PPP1R9A FAM124B	4.38e-05	194	89	5	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	4.38e-05	194	89	5	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 MKX SPARCL1 PDLIM5	4.38e-05	194	89	5	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MYH7B PPP1R9A PKP2 IQCJ-SCHIP1 PDLIM5	4.38e-05	194	89	5	c3535f7cc0076653c72db582047cff053c322397
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 MKX SPARCL1 PDLIM5	4.38e-05	194	89	5	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 MKX SPARCL1 PDLIM5	4.38e-05	194	89	5	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M AFF3 NAV2 PDLIM5 CNTN1	4.38e-05	194	89	5	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	MYH7 MYH7B PPP1R9A PKP2 PDLIM5	4.49e-05	195	89	5	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MYH7 MYH7B PPP1R9A PKP2 PDLIM5	4.49e-05	195	89	5	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAM171A1 MYO6 PPP1R9A CGNL1 LRBA	4.49e-05	195	89	5	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS3 AFF3 NAV3 NAV2 CNTN1	4.49e-05	195	89	5	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	ILEUM-inflamed-(6)_ILC3\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IRF2BP2 TNFSF13B PPP1R9A AFF3 FAM124B	4.49e-05	195	89	5	c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 MYO6 NAV2 MGA PCM1	4.49e-05	195	89	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO6 PPP1R9A NAV2 CGNL1 LRBA	4.49e-05	195	89	5	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Control-Neu_4\|Control / 5 Neutrophil clusters in COVID-19 patients	LEMD3 ASPM DIAPH2 MGA TASOR	4.60e-05	196	89	5	b8b7b54ca17a08fa775507bb22b1c7248ada8f40
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	A2M MYO6 TTC16 KIF19 NLRC5	4.60e-05	196	89	5	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M NAV3 NAV2 IQCJ-SCHIP1 CNTN1	4.71e-05	197	89	5	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SLAIN2 IRF2BP2 PPP2R5E RLIM DYNC2I1	4.94e-05	199	89	5	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD34 NAV3 SPARCL1 CGNL1 CNTN1	4.94e-05	199	89	5	103f657132e830a0e5efeb745afb4b77c208a1fa
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD34 NAV3 SPARCL1 CGNL1 CNTN1	4.94e-05	199	89	5	9846d6a31635fde759d55674631c11ab9270a603
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD34 NAV3 SPARCL1 CGNL1 CNTN1	4.94e-05	199	89	5	83383d9ae4f501754fd3da0215ce6f0e3c70562c
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	SLAIN2 PPP2R5E MYO6 RLIM CNTN1	4.94e-05	199	89	5	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	A2M CD34 SPARCL1 CGNL1 FAM124B	5.06e-05	200	89	5	5ec31c1be6bcc4124e1489d136570f3de33cc2e9
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A MYO6 SPARCL1 PDLIM5	5.06e-05	200	89	5	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FAM171A1 TUT4 PPP1R9A DIAPH2 FAM124B	5.06e-05	200	89	5	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A SPARCL1 IQCJ-SCHIP1 FAM124B	5.06e-05	200	89	5	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	tumor_Lung-Endothelial_cells-Tumor_ECs\|Endothelial_cells / Location, Cell class and cell subclass	A2M CD34 KIF19 SPARCL1 PDLIM5	5.06e-05	200	89	5	9c1b30fa96565515a7160f439cadcd51482c41e9
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M MYOC NAV3 NAV2 SPARCL1	5.06e-05	200	89	5	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A MYO6 CD34 FAM124B	5.06e-05	200	89	5	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAM171A1 PPP2R5A MYO6 CD34 FAM124B	5.06e-05	200	89	5	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
Drug	Sparteine (-) [90-39-1]; Up 200; 17uM; PC3; HT_HG-U133A	A2M CACNB1 CNTN5 NAV3 ABCC2 PDLIM5 JHY SPINK5	8.76e-07	199	86	8	4568_UP
Drug	formycin triphosphate	MYH7 MYO1A MYO6 MYH7B MYO15A	1.40e-06	51	86	5	CID000122274
Drug	purealin	MYH7 MYO1A MYO6 MYH7B MYO15A	2.68e-06	58	86	5	CID006419303
Drug	Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; PC3; HT_HG-U133A	A2M CACNB1 IGF1R PTPRH NAV3 ABCC2 PDLIM5	7.00e-06	187	86	7	4589_UP
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	MYOC CD34 AFF3 DIAPH2 PDLIM5 CNTN1 SPINK5	9.52e-06	196	86	7	6785_UP
Drug	nocodazole	RANBP2 MYH7 PPP2R5A PPP2R5E MYO6 MYH7B GOLIM4 GRAMD4 PCM1 CNTN1	1.27e-05	477	86	10	CID000004122
Disease	SPARC-like protein 1 measurement	DSPP DHX38 SPARCL1	4.27e-07	6	83	3	EFO_0008289
Disease	Left ventricular noncompaction	MYH7 MYH7B PKP2	7.64e-06	14	83	3	C1960469
Disease	neutropenia, leukopenia, chemotherapy-induced cytotoxicity measurement	TNFSF13B NLRC5	7.82e-06	2	83	2	EFO_0004233, EFO_0010978, MONDO_0001475
Disease	blood lead measurement, bone density	NAV2 WIPI2	2.34e-05	3	83	2	EFO_0003923, EFO_0007040
Disease	cardiomyopathy (implicated_via_orthology)	MYH7 MYH7B SPARCL1 PDLIM5	4.90e-05	71	83	4	DOID:0050700 (implicated_via_orthology)
Disease	atrial fibrillation	MYH7 IGF1R CNTN5 NAV2 PKP2 CGNL1 PCM1	8.58e-05	371	83	7	EFO_0000275
Disease	sensorineural hearing loss (is_implicated_in)	MYO1A MYO6 MYO15A	1.10e-04	33	83	3	DOID:10003 (is_implicated_in)
Disease	corpus callosum anterior volume measurement	NAV3 NAV2 IQCJ-SCHIP1	1.82e-04	39	83	3	EFO_0010295
Disease	QRS duration	IGF1R UBR5 MYH7B SIPA1L1 PDLIM5 CNTN1	1.98e-04	298	83	6	EFO_0005055
Disease	myopathy (implicated_via_orthology)	MYH7 MYH7B PDLIM5	3.39e-04	48	83	3	DOID:423 (implicated_via_orthology)
Disease	heart disease (is_marker_for)	A2M MYH7	3.47e-04	10	83	2	DOID:114 (is_marker_for)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH7 MYH7B	3.47e-04	10	83	2	DOID:0111596 (implicated_via_orthology)
Disease	monokine induced by gamma interferon measurement	ERCC6L2 FAM124B PHTF1	4.29e-04	52	83	3	EFO_0008236
Disease	distal myopathy (implicated_via_orthology)	MYH7 MYH7B	5.07e-04	12	83	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH7 MYH7B	5.07e-04	12	83	2	DOID:2106 (implicated_via_orthology)
Disease	Common variable immunodeficiency	IRF2BP2 LRBA	5.98e-04	13	83	2	cv:C0009447
Disease	rostral anterior cingulate cortex volume measurement	SFXN1 CGNL1	5.98e-04	13	83	2	EFO_0010327
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH7 MYH7B	5.98e-04	13	83	2	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH7 MYH7B	8.02e-04	15	83	2	DOID:0050646 (implicated_via_orthology)
Disease	Paroxysmal atrial fibrillation	MYH7 IGF1R NAV2 PKP2	9.99e-04	156	83	4	C0235480
Disease	familial atrial fibrillation	MYH7 IGF1R NAV2 PKP2	9.99e-04	156	83	4	C3468561
Disease	Persistent atrial fibrillation	MYH7 IGF1R NAV2 PKP2	9.99e-04	156	83	4	C2585653
Disease	Atrial Fibrillation	MYH7 IGF1R NAV2 PKP2	1.10e-03	160	83	4	C0004238
Disease	juvenile idiopathic arthritis	TSBP1 AFF3 PHTF1	1.20e-03	74	83	3	EFO_0002609
Disease	anthropometric measurement	IGF1R ADAMTS3 MKX PDLIM5	1.31e-03	168	83	4	EFO_0004302
Disease	age at menarche	IGF1R MYO6 CNTN5 AFF3 KDM3B PSMG3-AS1 JHY	1.43e-03	594	83	7	EFO_0004703
Disease	coagulation factor measurement	ASPM CNTN1	1.44e-03	20	83	2	EFO_0004634
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH7 MYH7B PDLIM5	1.51e-03	80	83	3	DOID:12930 (implicated_via_orthology)
Disease	total blood protein measurement	ZNF609 IQGAP2 TNFSF13B CD34 DHX38 AFF3	1.69e-03	449	83	6	EFO_0004536
Disease	hypertrophic cardiomyopathy (is_implicated_in)	MYH7 MYH7B	1.74e-03	22	83	2	DOID:11984 (is_implicated_in)
Disease	venous thromboembolism	SFXN1 IQGAP2 LEMD3 TNFSF13B SURF6 NAV2	1.91e-03	460	83	6	EFO_0004286
Disease	drug-induced liver injury	TSBP1 LRBA	2.07e-03	24	83	2	EFO_0004228
Disease	Dwarfism	ERCC4 KDM3B	2.25e-03	25	83	2	C0013336
Disease	Left ventricular mass to end-diastolic volume ratio	IGF1R SIPA1L1	2.25e-03	25	83	2	EFO_0010556
Disease	Micronuclei, Chromosome-Defective	ERCC4 PPP2R5E	2.43e-03	26	83	2	C1449861
Disease	Micronuclei, Genotoxicant-Induced	ERCC4 PPP2R5E	2.43e-03	26	83	2	C1449862
Disease	hearing impairment	MYO1A DSPP MYO15A	2.69e-03	98	83	3	C1384666
Disease	smoking behavior	IGF1R ERCC4 ADGRB2 NAV3 NAV2	2.78e-03	341	83	5	EFO_0004318

Protein segments in the cluster

Peptide	Gene	Start	Entry
RQKRSQSSSQFRSQG	PPP2R5E	26	Q16537
ANGTQQRSRKCSVAG	ADGRB2	436	O60241
SDGQQRATQQGSLRT	AFF3	156	P51826
LRQNRLGSSKSGDNS	CACNB1	176	Q02641
KGQAQASNGAERRSQ	GRAMD4	146	Q6IC98
AGATNRSNTNGNTDK	DSPP	146	Q9NZW4
GAQVNTQGEISNKRS	ANKRD61	156	A6NGH8
GRSNKRSAGNRAANE	DIAPH2	21	O60879
FNSVNVNGQRGENSK	ASPM	281	Q8IZT6
SQRQKDNGCFRSSGS	A2M	1071	P01023
AENSRGKNSFRGQLQ	CNTN5	371	O94779
GSSQQKNSGFRRSDD	RANBP2	1116	P49792
GNAKTVRNDNSSRFG	MYH7	231	P12883
QQQHRSGGRGNKTRN	LEMD3	51	Q9Y2U8
SGGRGNKTRNSNNNN	LEMD3	56	Q9Y2U8
RLGRQGNLSSSGNQE	FLG2	161	Q5D862
GNLSSSGNQEGSQKR	FLG2	166	Q5D862
SARKGRGDALSLQQN	FAM171A1	751	Q5VUB5
SQRNQVKISRSNSEG	JHY	611	Q6NUN7
QRAQAGSNQSRGKCG	PSMG3-AS1	81	Q96PY0
VNKRSVNVNAASGGV	NEDD1	321	Q8NHV4
RNEGGNSESSLKNRS	MGA	806	Q8IWI9
SFGNAKTVRNDNSSR	MYO15A	1356	Q9UKN7
GNAKTIRNNNSSRFG	MYO1A	146	Q9UBC5
NTGERSNTGERSNDK	SPINK5	831	Q9NQ38
RGSLNGGNRVNNAKN	KIAA1109	2626	Q2LD37
ESQNGEHRNRGASSK	DYNC2I1	291	Q8WVS4
ENNTASKRHVGRQAG	DDX60	946	Q8IY21
RQSKGDINTRNNGER	IGF1R	471	P08069
GNAKTLRNDNSSRFG	MYH7B	276	A7E2Y1
SQGRATAANNKRQLS	PCM1	121	Q15154
NNTRGNANKTQKDTG	PCM1	711	Q15154
TSSNRKNQLDTNGRR	PCM1	1236	Q15154
TLENGSNKGESAANR	MKX	281	Q8IYA7
SKVQGASNLNRRSQS	NAV3	261	Q8IVL0
SNAGRKTSLDGSQNQ	NAV3	1106	Q8IVL0
SEKSGQLRQGSAQSQ	KIF7	986	Q2M1P5
GARTAQLRKANDQSG	MYOC	31	Q99972
KGSRSQASGENSRNS	KDM3B	451	Q7LBC6
GKQSIRSQALGNQNS	LRBA	2036	P50851
ALQRRQEKSSQQNSG	ABCC2	256	Q92887
AEGQRRGSQGDSKQQ	PDLIM5	221	Q96HC4
QRQATKDAGQISGLN	HSPA9	201	P38646
QESDGQRKGAQSRSL	NLRC5	831	Q86WI3
AQETLNKGRQDSNSR	GOLIM4	96	O00461
LAGSERASQTQNRGQ	KIF19	251	Q2TAC6
GTSRGVQNASRTQNL	DCP1B	341	Q8IZD4
GANLRQRSAQQAGSK	ADAMTS3	1126	O15072
RSQRNQGKRSQGHSL	FAM124B	281	Q9H5Z6
QTLKSRAAGSAQGNN	CGNL1	586	Q0VF96
AENNRGKANSTGTLV	CNTN1	486	Q12860
QGRSRSQVNGNSGAL	FAM120C	1026	Q9NX05
EQGAQVNRRSAKGNT	FEM1A	171	Q9BSK4
QNQTTLGSSRAKLGN	C1RL	241	Q9NZP8
RNNDNSRNTDDKRNG	ERCC6L2	951	Q5T890
ANGANGSKAVARTAR	IRF2BP2	341	Q7Z5L9
NRGAQENGTGQATSR	CD34	356	P28906
KQNEQLRSRSGAVQG	SLAIN2	26	Q9P270
NGNRLGESANAAKQA	SFXN1	211	Q9H9B4
AGGQINSDQRRNLGS	IQGAP2	1126	Q13576
QQSRSLGAQSSKAGE	SPATA31A7	936	Q8IWB4
KTRGGSTTANNRRSQ	NAV2	296	Q8IVL1
GAGSRRRKGQQQQQQ	RSPO1	236	Q2MKA7
DRQNTQSDIGGSGKS	SIPA1L1	1186	O43166
RESGRKVQSGNINAA	CCT3	16	P49368
EKNQTFSRGGRQTEQ	SECISBP2L	326	Q93073
FSRGGRQTEQRNNSQ	SECISBP2L	331	Q93073
VNNGGTERGSNNARL	PRR32	146	B1ATL7
NQDNTEVKGASRAAG	WIPI2	21	Q9Y4P8
QQARTRAGKTQGSET	SURF6	26	O75683
GQARTNSTSAQKNER	IQCJ-SCHIP1	321	B3KU38
NNSRGEAIISGKQRS	TASOR	656	Q9UK61
KRSQGSSQFRSQGSQ	PPP2R5A	36	Q15172
QQSRSLGAQSSKAGE	SPATA31A3	936	Q5VYP0
SQLAQGRGAAQRSDN	TULP4	966	Q9NRJ4
QQSRSLGAQSSKAGE	SPATA31A1	936	Q5TZJ5
RKTVNGDGSRENGNN	PHTF1	166	Q9UMS5
QQSRSLGAQSSKAGE	SPATA31A5	936	Q5VU36
NRSSKHSQGLRDQGN	SPARCL1	176	Q14515
GTRSNQQRLGETQKA	RNF25	321	Q96BH1
SNDKGSGDQSAAQRR	RLIM	6	Q9NVW2
RQTGNTTRSGQRGNQ	RLIM	106	Q9NVW2
TRAGANSKGRRGSQN	ZNF609	401	O15014
NSKGRRGSQNSSEHR	ZNF609	406	O15014
SQANANQRSGRAGRT	DHX38	846	Q92620
QRRNSSKTRATQGQG	TTC16	716	Q8NEE8
STDTRKAGGQEQNGT	ERCC4	666	Q92889
LRGNDQSVSSVNKGN	ZMYM1	571	Q5SVZ6
NKSHGGRTSQQERGQ	RPTN	91	Q6XPR3
GEGNSSQNSRNKRAV	TNFSF13B	121	Q9Y275
CGGTARSQNSREENK	TSBP1	236	Q5SRN2
AGSAQQQGDQSIRTR	TUT4	1401	Q5TAX3
GKNGINSSRETRNAT	PTPRH	191	Q9HD43
QQTLARKGRSSVGNG	PKP2	61	Q99959
NNDGSKLNSNSGAGR	UBR5	86	O95071
AFGNAKTVRNNNSSR	MYO6	191	Q9UM54
VRKRQNSARNSGASD	NAPEPLD	21	Q6IQ20
SQQSRGRKYGSNVNR	PPP1R9A	51	Q9ULJ8